Gombotz Wayne 4
4 · Immune Design Corp. · Filed Aug 3, 2017
Insider Transaction Report
Form 4
Gombotz Wayne
Chief Development Officer
Transactions
- Sale
Common Stock
2017-08-01$11.40/sh−9,253$105,523→ 23,801 total - Exercise/Conversion
Stock Option (Rt to Buy)
2017-08-01−10,000→ 38,715 totalExercise: $1.31Exp: 2021-12-08→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2017-08-01$1.31/sh+10,000$13,100→ 33,054 total - Sale
Common Stock
2017-08-01$11.80/sh−747$8,813→ 23,054 total
Footnotes (4)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 7, 2017.
- [F2]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.70 to $11.65 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $11.70 to $11.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
- [F4]Fully vested and immediately exercisable.